This morning’s premarket spotlight wasn’t on the indexes—it was on earnings: some stocks took a hit, while others got a boost.
Hims & Hers reported a loss-making third quarter. It fell more than 11% by Monday’s close and kept sliding after hours. Put simply, selling branded weight-loss drugs and selling generics are two very different businesses when it comes to profits.
Trade Desk was the exact opposite: third-quarter results beat expectations, its guidance was raised, and the stock surged after hours.
The broader market was cooling off: Dow futures +0.38%, S&P 500 +0.16%, and the Nasdaq was basically flat. Nvidia is still in the hot seat: its board launched an independent investigation, and shares fell 4.27% on Monday—the only one in the AI pack that didn’t join the rally. MARA’s third-quarter revenue missed expectations, and shares fell 0.75% after hours.
One day of gains in the broader market doesn’t mean a reversal. Earnings season is the real test. Tonight at 21:30, the CPI will have the final say.
$HIMS $TTD
Hims & Hers reported a loss-making third quarter. It fell more than 11% by Monday’s close and kept sliding after hours. Put simply, selling branded weight-loss drugs and selling generics are two very different businesses when it comes to profits.
Trade Desk was the exact opposite: third-quarter results beat expectations, its guidance was raised, and the stock surged after hours.
The broader market was cooling off: Dow futures +0.38%, S&P 500 +0.16%, and the Nasdaq was basically flat. Nvidia is still in the hot seat: its board launched an independent investigation, and shares fell 4.27% on Monday—the only one in the AI pack that didn’t join the rally. MARA’s third-quarter revenue missed expectations, and shares fell 0.75% after hours.
One day of gains in the broader market doesn’t mean a reversal. Earnings season is the real test. Tonight at 21:30, the CPI will have the final say.
$HIMS $TTD
